Most Popular
-
1
Over 80,000 millionaires, 20 billionaires in Seoul: report
-
2
Korean battery makers heave sigh of relief over 2-year IRA reprieve
-
3
Young Korean doctors seek plan B: cosmetic dermatology or overseas
-
4
Yoon apologizes over first lady’s Dior bag scandal, but accuses special probe attempt as political maneuvering
-
5
South Korea open to Indonesian proposal to cut KF-21 payments
-
6
Police seek arrest warrant for med student who killed girlfriend
-
7
Coupang earnings hit hard by losses from ailing Farfetch
-
8
[K-pop’s dilemma] Time, profit pressures work against originality
![[K-pop’s dilemma] Time, profit pressures work against originality](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/08/20240508050705_0.jpg&u=20240508171126)
-
9
Girl hanging on bridge, police trying to rescue her both fall off; rescued immediately
-
10
[K-pop's dilemma] Is Hybe-Ador conflict a case of growing pains?
![[K-pop's dilemma] Is Hybe-Ador conflict a case of growing pains?](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/07/20240507050746_0.jpg&u=)
![[K-pop’s dilemma] Time, profit pressures work against originality](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/08/20240508050705_0.jpg&u=20240508171126)
![[K-pop's dilemma] Is Hybe-Ador conflict a case of growing pains?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/07/20240507050746_0.jpg&u=)
Daewoong Pharmaceutical launched Nabota, a botulinum toxin-type formula, developed through the drugmaker’s local technology.
According to Dr. Kim Bum-joon, who supervised the clinical trials, Nabota was effective with moderate to severe glabellar lines and showed no significant difference in terms of safety and efficacy when compared with its competitors.
Daewoong said Nabota is already scheduled to be exported to the U.S., Europe, the Middle East and South America.
(baejisook@heraldcorp.com)
According to Dr. Kim Bum-joon, who supervised the clinical trials, Nabota was effective with moderate to severe glabellar lines and showed no significant difference in terms of safety and efficacy when compared with its competitors.
Daewoong said Nabota is already scheduled to be exported to the U.S., Europe, the Middle East and South America.
(baejisook@heraldcorp.com)
-
Articles by Korea Herald
![[Today’s K-pop] Stray Kids to drop new album in July: report](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/05/09/20240509050659_0.jpg&u=)